Mouse Anti-HAX1 Recombinant Antibody (9G3D11) (CBMAB-AO548LY)

Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Slows down the rate of inactivation of KCNC3 channels (PubMed:26997484).
Promotes GNA13-mediated cell migration. Involved in the clathrin-mediated endocytosis pathway. May be involved in internalization of ABC transporters such as ABCB11. May inhibit CASP9 and CASP3. Promotes cell survival. May regulate intracellular calcium pools.
Negative regulation of apoptotic process Source: UniProtKB
Positive regulation of actin cytoskeleton reorganization Source: BHF-UCL
Positive regulation of granulocyte differentiation Source: BHF-UCL
Positive regulation of peptidyl-serine phosphorylation Source: BHF-UCL
Positive regulation of peptidyl-tyrosine phosphorylation Source: BHF-UCL
Positive regulation of phosphatidylinositol 3-kinase signaling Source: BHF-UCL
Positive regulation of protein kinase B signaling Source: BHF-UCL
Positive regulation of transcription by RNA polymerase II Source: BHF-UCL
Regulation of actin filament polymerization Source: BHF-UCL
Regulation of apoptotic process Source: ParkinsonsUK-UCL
Regulation of autophagy of mitochondrion Source: ParkinsonsUK-UCL
Regulation of protein targeting to mitochondrion Source: ParkinsonsUK-UCL
Isoform 1: Cytoplasm; Nucleus. Predominantly cytoplasmic. Also detected in the nucleus when nuclear export is inhibited, and in response to cellular stress caused by arsenite (in vitro).
Isoform 3: Cytoplasm; Nucleus. Predominantly cytoplasmic. Also detected in the nucleus when nuclear export is inhibited (in vitro).
Isoform 4: Cytoplasm; Nucleus. Shuttles between nucleus and cytoplasm.
Isoform 5: Cytoplasm. Predominantly cytoplasmic.
The disease is caused by variants affecting the gene represented in this entry. The clinical phenotype due to HAX1 deficiency appears to depend on the localization of the mutations and their influence on the transcript variants. Mutations affecting exclusively isoform 1 are associated with isolated congenital neutropenia, whereas mutations affecting both isoform 1 and isoform 5 are associated with additional neurologic symptoms (PubMed:18337561). A disorder of hematopoiesis characterized by maturation arrest of granulopoiesis at the level of promyelocytes with peripheral blood absolute neutrophil counts below 0.5 x 10(9)/l and early onset of severe bacterial infections. Some patients affected by severe congenital neutropenia type 3 have neurological manifestations such as psychomotor retardation and seizures.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Alternative Versions
Mouse Anti-HAX1 (N-terminus) Recombinant Antibody (9G3D11) (CAT#: CBMAB-H1613-FY)
Related Products
Mouse Anti-HAX1 Recombinant Antibody (CBFYH-0723) (CAT#: CBMAB-H0632-FY)
Mouse Anti-HAX1 (AA 1-279) Recombinant Antibody (CBFYH-0725) (CAT#: CBMAB-H1615-FY)
Mouse Anti-HAX1 (N-terminus) Recombinant Antibody (CBFYH-3522) (CAT#: CBMAB-H4073-FY)
Mouse Anti-HAX1 Recombinant Antibody (2B12) (CAT#: CBMAB-A3749-LY)
Mouse Anti-HAX1 Recombinant Antibody (1D2) (CAT#: CBMAB-A3748-LY)
Mouse Anti-HAX1 (N-terminus) Recombinant Antibody (9G3D11) (CAT#: CBMAB-H1613-FY)
Mouse Anti-HAX1 Recombinant Antibody (8F9G7) (CAT#: CBMAB-AO547LY)
Mouse Anti-HAX1 (N-terminus) Recombinant Antibody (CBFYH-3520) (CAT#: CBMAB-H4071-FY)
Mouse Anti-HAX1 (AA 1-279) Recombinant Antibody (CBFYH-0722) (CAT#: CBMAB-H0472-FY)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
